LEKTI-6 (Haemopep)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLEKTI-6 (Haemopep)
Drug Alias NameLEKTI-6
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionKallikrein-5 inhibitorsKallikrein-7 inhibitors
TargetsKallikrein-5Kallikrein-7
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHaemopep Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHaemopep Pharma GmbH
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A